Experiment 954945
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | STEWART,JA: LOW,JB: ROBERTS,JD: BLOW,A:. (1991). A PHASE I CLINICAL TRIAL OF DIDEMNIN B.. 68(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | 35 PATIENTS WITH ADVANCED CANCER WERE USED IN THIS PHASE I STUDY. THE DAILY DOSE LEVELS RANGED FROM 0.03 TO 2.00 MG/M2. DOSE LIMITING TOXICITIES WERE NAUSEA AND VOMITING. OTHER TOXICITIES INCLUDED ELEVATED HEPATIC ENZYME LEVELS, LEUKOPENIA, DIARRHEA, THROMBOCYTOPENIA, ANAPHYLACTIC SYMPTOMS AND INCREASED CLOTTING TIME. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |